These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15110788)

  • 21. Asymmetric RNA duplexes mediate RNA interference in mammalian cells.
    Sun X; Rogoff HA; Li CJ
    Nat Biotechnol; 2008 Dec; 26(12):1379-82. PubMed ID: 19029911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of thiophosphate substitutions on native siRNA gene silencing.
    Li ZY; Mao H; Kallick DA; Gorenstein DG
    Biochem Biophys Res Commun; 2005 Apr; 329(3):1026-30. PubMed ID: 15752758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Silencing lamin A/C in human endometrial stromal cells: a model to investigate endometrial gene function and regulation.
    Tulac S; Dosiou C; Suchanek E; Giudice LC
    Mol Hum Reprod; 2004 Oct; 10(10):705-11. PubMed ID: 15347737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A systematic analysis of the silencing effects of an active siRNA at all single-nucleotide mismatched target sites.
    Du Q; Thonberg H; Wang J; Wahlestedt C; Liang Z
    Nucleic Acids Res; 2005; 33(5):1671-7. PubMed ID: 15781493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure and sequence motifs of siRNA linked with in vitro down-regulation of morbillivirus gene expression.
    de Almeida RS; Keita D; Libeau G; Albina E
    Antiviral Res; 2008 Jul; 79(1):37-48. PubMed ID: 18394725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of siRNA nuclease stability on the in vitro and in vivo kinetics of siRNA-mediated gene silencing.
    Bartlett DW; Davis ME
    Biotechnol Bioeng; 2007 Jul; 97(4):909-21. PubMed ID: 17154307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design of a genome-wide siRNA library using an artificial neural network.
    Huesken D; Lange J; Mickanin C; Weiler J; Asselbergs F; Warner J; Meloon B; Engel S; Rosenberg A; Cohen D; Labow M; Reinhardt M; Natt F; Hall J
    Nat Biotechnol; 2005 Aug; 23(8):995-1001. PubMed ID: 16025102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimization of an siRNA-expression system with an improved hairpin and its significant suppressive effects in mammalian cells.
    Miyagishi M; Sumimoto H; Miyoshi H; Kawakami Y; Taira K
    J Gene Med; 2004 Jul; 6(7):715-23. PubMed ID: 15241778
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of internally nuclease-protected single-strand DNA oligonucleotides and silencing of the mismatch repair protein, MSH2, enhances the replication of corrected cells following gene editing.
    Papaioannou I; Disterer P; Owen JS
    J Gene Med; 2009 Mar; 11(3):267-74. PubMed ID: 19153972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene silencing of human RAMP2 mediated by short-interfering RNA.
    Albertin G; Ruggero M; Guidolin D; Nussdorfer GG
    Int J Mol Med; 2006 Oct; 18(4):531-5. PubMed ID: 16964401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimal design and validation of antiviral siRNA for targeting hepatitis B virus.
    Fu J; Tang ZM; Gao X; Zhao F; Zhong H; Wen MR; Sun X; Song HF; Qian XH
    Acta Pharmacol Sin; 2008 Dec; 29(12):1522-8. PubMed ID: 19026173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An algorithm for selection of functional siRNA sequences.
    Amarzguioui M; Prydz H
    Biochem Biophys Res Commun; 2004 Apr; 316(4):1050-8. PubMed ID: 15044091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selection and validation of optimal siRNA target sites for RNAi-mediated gene silencing.
    Luo Q; Kang Q; Song WX; Luu HH; Luo X; An N; Luo J; Deng ZL; Jiang W; Yin H; Chen J; Sharff KA; Tang N; Bennett E; Haydon RC; He TC
    Gene; 2007 Jun; 395(1-2):160-9. PubMed ID: 17449199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppression of bcr-abl synthesis by siRNAs or tyrosine kinase activity by Glivec alters different oncogenes, apoptotic/antiapoptotic genes and cell proliferation factors (microarray study).
    Zhelev Z; Bakalova R; Ohba H; Ewis A; Ishikawa M; Shinohara Y; Baba Y
    FEBS Lett; 2004 Jul; 570(1-3):195-204. PubMed ID: 15251464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The dialectics of cancer: A theory of the initiation and development of cancer through errors in RNAi.
    Wynter CV
    Med Hypotheses; 2006; 66(3):612-35. PubMed ID: 16359827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of RNA interference to chicken embryos using small interfering RNA.
    Sato F; Nakagawa T; Ito M; Kitagawa Y; Hattori MA
    J Exp Zool A Comp Exp Biol; 2004 Oct; 301(10):820-7. PubMed ID: 15449340
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Knocking (anti)-sense into cells: the microsphere approach to gene silencing.
    Alexander LM; Sánchez-Martín RM; Bradley M
    Bioconjug Chem; 2009 Mar; 20(3):422-6. PubMed ID: 19245252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chimeric capsid protein as a nanocarrier for siRNA delivery: stability and cellular uptake of encapsulated siRNA.
    Choi KM; Choi SH; Jeon H; Kim IS; Ahn HJ
    ACS Nano; 2011 Nov; 5(11):8690-9. PubMed ID: 21985460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis, gene silencing, and molecular modeling studies of 4'-C-aminomethyl-2'-O-methyl modified small interfering RNAs.
    Gore KR; Nawale GN; Harikrishna S; Chittoor VG; Pandey SK; Höbartner C; Patankar S; Pradeepkumar PI
    J Org Chem; 2012 Apr; 77(7):3233-45. PubMed ID: 22372696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specific residues at every third position of siRNA shape its efficient RNAi activity.
    Katoh T; Suzuki T
    Nucleic Acids Res; 2007; 35(4):e27. PubMed ID: 17259216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.